Mode
Text Size
Log in / Sign up

Oncology

864 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients
Oncology Cohort
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients New tool better predicts lung damage from radiation therapy
This cohort study of 580 lung cancer patients found that QUANTEC and Appelt NTCP models systematically underestimated radiation pneumonitis …
A new risk model more accurately predicts lung injury after modern radiation therapy for lung cancer, helping doctors tailor safer treatment…
Modified thin-slab volume rendering improves diagnostic performance for pneumonic-type lung cancer and inflammatory pneumonia
Oncology Cohort
Modified thin-slab volume rendering improves diagnostic performance for pneumonic-type lung cancer and inflammatory pneumonia New Imaging Trick Tells Cancer and Pneumonia Apart
This retrospective cohort study evaluated modified thin-slab volume rendering (tsVR) with densitometry-derived thresholds against convention…
Doctors can now tell aggressive lung cancer apart from pneumonia more accurately using a simple tweak to CT scans that highlights subtle dif…
Deep Learning MRI Models Predict Treatment Response in Hepatocellular Carcinoma Following Transarterial Chemoembolization
Oncology Cohort
Deep Learning MRI Models Predict Treatment Response in Hepatocellular Carcinoma Following Transarterial Chemoembolization AI Models Predict Liver Cancer Treatment Response Better Than Standard Scores
This cohort study evaluated AI models using gadoxetic acid–enhanced MRI in 160 patients with Barcelona Clinic Liver Cancer stage A or B hepa…
Artificial intelligence using MRI scans predicted how patients with liver cancer would respond to treatment more accurately than standard cl…
Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients
Oncology Cohort
Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients After Surgery, This Extra Step May Extend Survival in Rare Cancer
This retrospective cohort study evaluated 98 patients with resectable stage I-III duodenal adenocarcinoma at two Chinese institutions.
After surgery for duodenal cancer, adding chemotherapy may nearly double survival time, but larger trials are still needed.
Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer
Oncology Meta-analysis
Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer Robotic surgery shows lower urinary retention for rectal cancer patients in a review of 6,121 cases
This systematic review and meta-analysis evaluated robotic versus laparoscopic surgery in 6121 rectal cancer patients with 12.0 months of fo…
A review of 6,121 rectal cancer patients found robotic surgery led to less urinary retention than laparoscopic surgery, though other functio…
Systematic review and meta-analysis compares subcutaneous versus intravenous PD-1/PD-L1 inhibitors for solid tumors
Oncology Meta-analysis
Systematic review and meta-analysis compares subcutaneous versus intravenous PD-1/PD-L1 inhibitors for solid tumors Subcutaneous shots match intravenous drugs for cancer survival and response rates in solid tumors
This systematic review and meta-analysis of 1243 patients with solid tumors found no significant difference in overall survival, progression…
A large review found that giving cancer drugs under the skin works just as well as the traditional vein injection for patients with solid tu…
Specialized palliative care intervention enrollment patterns in a glioblastoma randomized controlled trial sub-analysis
Oncology RCT
Specialized palliative care intervention enrollment patterns in a glioblastoma randomized controlled trial sub-analysis Glioblastoma trial reveals why patients skip or delay visits
This sub-analysis of the Early Palliative Care for Patients with Glioblastoma (EPCOG) trial examined enrollment and retention among 556 scre…
Many glioblastoma patients skip or delay study visits due to illness or lack of interest, a new trial analysis finds.
Abexinostat showed a 69.5% objective response rate in relapsed follicular lymphoma patients
Oncology Phase II
Abexinostat showed a 69.5% objective response rate in relapsed follicular lymphoma patients New Drug Shrinks Stubborn Lymphoma Tumors After Other Treatments Fail
This single-arm, multi-center phase 2 study evaluated abexinostat in 90 patients with relapsed or refractory follicular lymphoma who had rec…
A new treatment is helping some patients with stubborn lymphoma shrink tumors and stay in control for over a year, even after other therapie…
Narrative review suggests multi-omics AI models improve glioma radiotherapy response prediction over single-modality approaches
Oncology Sys. Review
Narrative review suggests multi-omics AI models improve glioma radiotherapy response prediction over single-modality approaches Glioma Radiotherapy Gets Smarter With Biomarker-Guided Dosing
This narrative review synthesizes evidence regarding multi-omics artificial intelligence models for predicting radiotherapy response in glio…
New biomarkers may help doctors tailor radiation doses for glioma patients, improving outcomes and reducing side effects.
Taxane-Based and Long-Course Chemotherapy Linked to Higher Breast Cancer-Related Lymphedema Risk
Oncology Cohort
Taxane-Based and Long-Course Chemotherapy Linked to Higher Breast Cancer-Related Lymphedema Risk New Data Links Chemo Drugs to Arm Swelling in Breast Cancer
In a retrospective cohort of 201 breast cancer patients at Guangzhou Red Cross Hospital, taxane-based regimens, long-course chemotherapy, an…
Breast cancer patients on certain chemotherapy drugs face a higher risk of developing arm swelling after treatment ends.
3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases
Oncology Cohort
3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases New AI Tool Grades Pediatric Brain Tumors With 91% Accuracy
This retrospective cohort review evaluated a 3D C-Vit model against clinical and radiomics models in 340 pediatric brain tumor cases.
A new AI tool grades pediatric brain tumors with 91% accuracy, helping doctors plan treatment faster and more reliably.
Adjuvant Imatinib Beyond 3 Years in High-Risk GIST: 5-Year Relapse-Free Survival Outcomes
Oncology Cohort
Adjuvant Imatinib Beyond 3 Years in High-Risk GIST: 5-Year Relapse-Free Survival Outcomes Extending Imatinib beyond 3 years did not improve survival for high-risk GIST patients
This retrospective cohort study evaluated adjuvant imatinib duration in 75 patients with high-risk GIST after radical surgery.
A look at past data shows taking Imatinib longer than three years did not help high-risk GIST patients live longer or stay cancer-free.